# US 2024/0392340 A1 · Enzymes, host cells, and methods for biosynthesis of dammarenediol and derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0392340 A1
- Document ID: US20240392340A1
- Status: Published application
- Kind: A1
- Application number: 18/690,805
- Filed: 2022-09-09
- Published: 2024-11-28
- Earliest claimed: 2021-09-09
- Assignees: Manus Bio Inc.
- Applicants: Manus Bio Inc.
- Inventors: Ajikumar PARAYIL KUMARAN; Christine Nicole S. SANTOS; Lu CHEN; Liwei LI; Chin Giaw LIM
- Web page: https://patentgrep.com/patent/US20240392340A1

## CPC

- C12P 33/06: Hydroxylating
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 9/1051: {Hexosyltransferases (2.4.1)}
- C12N 9/1085: {transferring alkyl or aryl groups other than methyl groups (2.5)}
- C12N 9/88: Lyases (4.)
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12P 33/00: Preparation of steroids
- C12R 2001/19: Escherichia coli
- C12Y 114/14: with reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen (1.14.14)
- C12Y 204/01017: Glucuronosyltransferase (2.4.1.17)
- C12Y 205/01021: Squalene synthase (2.5.1.21), i.e. farnesyl-disphosphate farnesyltransferase
- C12Y 402/01125: Dammarenediol II synthase (4.2.1.125)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12Y: ENZYMES

## Abstract

The disclosure provides compositions and methods related to engineered microbial cells, enzymes, and methods for producing dammarenediol, as well as compounds derived from dammarenediol. Microbial host cells are engineered to express a heterologous biosynthetic pathway that produces dammarenediol, or a derivative thereof. The host cell can optionally express a heterologous uridine diphosphate-dependent glycosyltransferase (UGT) enzyme producing natural or non-natural glycosylated forms of dammarenediol, protopanaxadiol or protopanaxatriol.

## Claims

### Claim 1

A method for producing dammarenediol or a derivative thereof, comprising:
providing a microbial host cell expressing a heterologous biosynthetic pathway producing dammarenediol or a derivative thereof, the heterologous biosynthetic pathway comprising one or more of:
a dammarenediol synthase (DDS) enzyme comprising an amino acid sequence that has at least about 70% sequence identity to the amino acid sequence of SEQ ID NO: 3, SEQ ID NO: 4, or SEQ ID NO: 9;
a protopanaxadiol synthase (PPDS) enzyme comprising an amino acid sequence that has at least 70% sequence identity to the amino acid sequence of SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, or SEQ ID NO: 16; and
a protopanaxatriol synthase (PPTS) enzyme comprising an amino acid sequence that has at least 70% sequence identity to the amino acid sequence of SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, and SEQ ID NO: 21.

### Claim 2 (depends on 1)

The method of claim 1, wherein the DDS enzyme comprises an amino acid sequence having at least 80% sequence identity, or at least 85% sequence identity, or at least 90% sequence identity, or at least 95% sequence identity, or at least 97% sequence identity, or at least 98% sequence identity, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 3, SEQ ID NO: 4, or SEQ ID NO: 9.

### Claim 3 (depends on 1)

The method of claim 1, wherein the DDS enzyme comprises an amino acid sequence having at least 70% sequence identity, or at least 80% sequence identity, or at least 85% sequence identity, or at least 90% sequence identity, or at least 95% sequence identity, or at least 97% sequence identity, or at least 98% sequence identity, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 3.

### Claim 4 (depends on 3)

The method of claim 3, wherein the DDS enzyme comprises from 1 to 20, or from 1 to 10, or from 1 to 5 amino acid modifications independently selected from substitutions, deletions, and insertions with respect to SEQ ID NO: 3.

### Claim 5 (depends on 3, 4)

The method of claim 3 or claim 4, wherein the DDS enzyme comprises one or more substitutions at positions selected from 606, 628, and 632 with respect to SEQ ID NO: 3.

### Claim 6 (depends on 5)

The method of claim 5, wherein the DDS enzyme comprises one or more substitutions selected from N606I, N606L, N606V, T628A, T628V, T628G, F632L, F632I, F632V, and F632A with respect to SEQ ID NO: 3.

### Claim 7 (depends on 6)

The method of claim 6, wherein the DDS enzyme comprises one or more substitutions selected from N606I, T628A, and F632L with respect to SEQ ID NO: 3, and wherein the DDS enzyme optionally comprises the amino acid sequence of SEQ ID NO: 5.

### Claim 8 (depends on 3, 4)

The method of claim 3 or claim 4, wherein the DDS enzyme comprises one or more substitutions at positions selected from 365, 369, and 461 with respect to SEQ ID NO: 3.

### Claim 9 (depends on 8)

The method of claim 8, wherein the DDS enzyme comprises one or more substitutions selected from T365E, T365D, F369Y, R461T, and R461S with respect to SEQ ID NO: 3.

### Claim 10 (depends on 9)

The method of claim 9, wherein the DDS enzyme comprises one or more substitutions selected from T365E, F369Y, and R461S with respect to SEQ ID NO: 3, and wherein the DDS enzyme optionally comprises the amino acid sequence of SEQ ID NO: 6.

### Claim 11 (depends on 3, 4)

The method of claim 3 or claim 4, wherein the DDS enzyme comprises one or more substitutions at positions selected from 30, 64, and 68 with respect to SEQ ID NO: 3.

### Claim 12 (depends on 11)

The method of claim 11, wherein the DDS enzyme comprises one or more substitutions selected from Q30D, Q30E, M64L, M64I, M64V, M64A, and R68M with respect to SEQ ID NO: 3.

### Claim 13 (depends on 12)

The method of claim 12, wherein the DDS enzyme comprises one or more substitutions selected from Q30D, M64L, and R68M with respect to SEQ ID NO: 3, wherein the DDS enzyme optionally comprises the amino acid sequence of SEQ ID NO: 7.

### Claim 14 (depends on 3, 4)

The method of claim 3 or claim 4, wherein the DDS enzyme comprises one or more substitutions at positions selected from 425, 465, and 468 with respect to SEQ ID NO: 3.

### Claim 15 (depends on 14)

The method of claim 14, wherein the DDS enzyme comprises one or more substitutions selected from L465K, L465R, L465H, C468Y, C468F, C468W, I425G, I424V, and I424A with respect to SEQ ID NO: 3.

### Claim 16 (depends on 15)

The method of claim 15, wherein the DDS enzyme comprises one or more substitutions selected from L465K, C468Y, and I425A with respect to SEQ ID NO: 3, wherein the DDS enzyme optionally comprises the amino acid sequence of SEQ ID NO: 8.

### Claim 17 (depends on 3, 4)

The method of claim 3 or claim 4, wherein the DDS enzyme comprises one or more substitutions at positions corresponding to positions selected from 30, 64, 68, 365, 369, 425, 461, 465, 468, 606, 628, and 632 with respect to SEQ ID NO: 3.

### Claim 18 (depends on 17)

The method of claim 17, wherein the DDS enzyme comprises at least 2, or at least 3, or at least 4 substitutions at positions corresponding to positions selected from 30, 64, 68, 365, 369, 425, 461, 465, 468, 606, 628, and 632 with respect to SEQ ID NO: 3.

### Claim 19 (depends on 3, 4)

The method of claim 3 or 4, wherein the DDS enzyme comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 7, and has one or more substitutions with respect to SEQ ID NO: 7 selected from: T364E, T364D, F368Y, R460S, R460T, L464K, L464R, C467Y, and I424A.

### Claim 20 (depends on 19)

The method of claim 19, wherein the DDS enzyme comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 7, and has two, three, or more substitutions with respect to SEQ ID NO: 7 selected from: T364E, F368Y, R460S, L464K, C467Y, and I424A.

### Claim 21 (depends on 20)

The method of claim 20, wherein the DDS enzyme comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 7, and has at least the following substitutions with respect to SEQ ID NO: 7: T364E, F368Y, R460S, L464K, C467Y, and I424A, and wherein the DDS enzyme optionally has the amino acid sequence of SEQ ID NO: 81.

### Claim 22 (depends on 3)

The method of claim 3, wherein the DDS enzyme comprises an amino acid sequence that is at least 90% identical, or at least 95% identical, or at least 97% identical, or at least 98% identical to SEQ ID NO: 81.

### Claim 23 (depends on 22)

The method of claim 22, wherein the DDS enzymes comprises one or more mutations with respect to SEQ ID NO: 81 listed in Table 1.

### Claim 24 (depends on 23)

The method of claim 23, wherein the DDS enzyme comprises two, three, four, five, or more mutations with respect to SEQ ID NO: 81 listed in Table 1.

### Claim 25 (depends on 24)

The method of claim 24, wherein the DDS enzyme has one or more of the following mutations with respect to SEQ ID NO: 81: Y49F, S181T, deletion of amino acids L195-E197, S198P, E238S, I407V, D507E, R637K, and M695I, and the DDS enzyme optionally comprises the amino acid sequence of SEQ ID NO: 82.

### Claim 26 (depends on 3)

The method of claim 3, wherein the DDS enzyme comprises an amino acid sequence that is at least 90% identical, or at least 95% identical, or at least 97% identical, or at least 98% identical to SEQ ID NO: 82.

### Claim 27 (depends on 26)

The method of claim 26, wherein the DDS enzyme comprises one or more mutations with respect to SEQ ID NO: 82 listed in Table 2.

### Claim 28 (depends on 27)

The method of claim 27, wherein the DDS enzyme comprises two, three, four, five, or more mutations with respect to SEQ ID NO: 82 listed in Table 2.

### Claim 29 (depends on 26)

The method of claim 26, wherein the DDS enzyme comprises one or more mutations with respect to SEQ ID NO: 82 selected from: F649L, F649V, F649I, F649A, L548F, Q149E, Q149D, A120S, A120T, G573A, G573L, S380A, S380G, and A256G.

### Claim 30 (depends on 29)

The method of claim 29, wherein the DDS enzyme comprises two, three, four, five, or all mutations with respect to SEQ ID NO: 82 selected from: F649L, L548F, Q149E, A120S, G573A, S380A, and A256G.

### Claim 31 (depends on 1)

The method of claim 1, wherein the heterologous biosynthetic pathway comprises a DDS enzyme comprising an amino acid sequence that is at least 90%, or at least 95%, or at least 97%, or at least 98%, or at least 99% identical to SEQ ID NO: 85.

### Claim 32 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The method of any one of claims 1 to 31, wherein the heterologous biosynthetic pathway comprises a PPDS enzyme comprising an amino acid sequence that has at least 70% sequence identity to the amino acid sequence of SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 14, SEQ ID NO: 15, or SEQ ID NO: 16.

### Claim 33 (depends on 32)

The method of claim 32, wherein the PPDS enzyme comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to an amino acid sequence selected from SEQ ID NOs: 10, 11, 12 and 16.

### Claim 34 (depends on 33)

The method of claim 33, wherein the PPDS enzyme comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 10.

### Claim 35 (depends on 34)

The method of claim 34, wherein the PPDS enzyme comprises from 1 to 20, or from 1 to 10, or from 1 to 5 amino acid substitutions with respect to SEQ ID NO: 10.

### Claim 36 (depends on 34, 35)

The method of claim 34 or claim 35, wherein the PPDS enzyme comprises one or more substitutions selected from N58D, N58E, S68P, R85K, I95V, L96F, L96W, L96Y, T108N, T108Q, D135E, M144L, M144V, M144I, V150P, G152A, G152L, G152I, G152V, M153L, M153I, M153V, M153A, F167H, S192A, S192G, E202P, I212F, R243K, R243H, V248I, V248L,N277D, N277E, Q278E, Q278D, L283M, L292I, L292V, L292A, F317L, F317I, F317V, F317A, V329M, N333K, N333R, K338G, K338A, L346I, R347Q, R347N, I362L, I362V, I362A, M390L, M390I, M390V, M390A, H482R, and H482K with respect to SEQ ID NO: 10.

### Claim 37 (depends on 36)

The method of claim 36, wherein the PPDS enzyme comprises at least 2, or at least 3, or at least 4, or at least 5, or at least 8, or at least 10 amino acid substitutions at positions disclosed in Table 3.

### Claim 38 (depends on 37)

The method of claim 37, wherein the PPDS enzyme comprises at least one, two, three, four, five, six, seven, eight, or all of the following mutations with respect to SEQ ID NO: 10: T108N, I212F, K338G, D135E, S68P, V150P, F167H, L283M, H482R, R347Q, M390L, R243K, L292I, V329M, Q278E, and N58E.

### Claim 39 (depends on 38)

The method of claim 38, wherein the PPDS comprises the amino acid sequence of SEQ ID NO: 83, optionally with from 1 to 10 or from 1 to 5 amino acid modifications independently selected from substitutions, insertions, and deletions.

### Claim 40 (depends on 1)

The method of claim 1, wherein the heterologous biosynthetic pathway comprises a PPDS enzyme comprising an amino acid sequence that is at least 90%, or at least 95%, or at least 97%, or at least 98%, or at least 99% identical to SEQ ID NO: 83.

### Claim 41 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40)

The method of any one of claims 1 to 40, wherein the heterologous biosynthetic pathway comprises a PPTS enzyme comprising an amino acid sequence that has at least 70% sequence identity to an amino acid sequence selected from SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20 and SEQ ID NO: 21.

### Claim 42 (depends on 41)

The method of claim 41, wherein the PPTS enzyme comprises an amino acid sequence that has at least 70% sequence identity, or at least 80% sequence identity, or at least 85% sequence identity, or at least 90% sequence identity, or at least 95% sequence identity, or at least 97% sequence identity, or at least 98% sequence identity to an amino acid sequence selected from SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20 and SEQ ID NO: 21.

### Claim 43 (depends on 42)

The method of claim 42, wherein the PPTS enzyme comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 17.

### Claim 44 (depends on 43)

The method of claim 43, wherein the PPTS enzyme comprises from 1 to 20, or from 1 to 10, or from 1 to 5 amino acid substitutions with respect to SEQ ID NO: 17.

### Claim 45 (depends on 43, 44)

The method of claim 43 or 44, wherein the PPTS enzyme comprises one or more substitutions with respect to SEQ ID NO: 17 selected from: 198L, 198V, 198A, A113S, A120S, A120T, K146R, F147Y, S166K, S166R, E176K, E176R, W185R, W185K, L187F, L187Y, L187W, L215I, F217L, F217I, F217V, F217A, V239I, V239L, V239A, R244K, K247L, K247V, K247I, K247A, Q249E, Q249D, T250P, K252Q, K252N, M259L, M259I, M259V, V278I, G294T, G294S, A323P, E324G, E324A, S328N, S328Q, R334K, V358E, V358D, V359A, V359G, K362D, K362E, S364T, N367G, N367A, I369T, I369S, K391P, M407A, M407G, F409Y, I412V, F426Y, V431I, V431L, N463K, N463R, and C472H.

### Claim 46 (depends on 45)

The method of claim 45, wherein the PPTS enzyme comprises at least 2, or at least 3, or at least 4, or at least 5, or at least 8, or at least 10 amino acid substitutions with respect to SEQ ID NO: 17 as listed in Table 4.

### Claim 47 (depends on 46)

The method of claim 46, wherein the PPTS enzyme comprises at least two, at least 3, at least 4, at least 5, or all amino acid substitutions selected from SEQ ID NO: 17 selected from: G294T, S166K, C472H, K252Q, V239I, A323P, I412V, I369T, K362D, and T250P.

### Claim 48 (depends on 47)

The method of claim 47, wherein the PPTS comprises the amino acid sequence of SEQ ID NO: 84, optionally with from 1 to 10 or from 1 to 5 amino acid modifications independently selected from substitutions, insertions, and deletions.

### Claim 49 (depends on 1)

The method of claim 1, wherein the heterologous biosynthetic pathway comprises a PPTS enzyme comprising an amino acid sequence that is at least 90%, or at least 95%, or at least 97%, or at least 98%, or at least 99% identical to SEQ ID NO: 84.

### Claim 50 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49)

The method of any one of claims 1 to 49, wherein the heterologous biosynthetic pathway further comprises one or more uridine diphosphate-dependent glycosyltransferase (UGT) enzymes that glycosylate one or more of dammaranediol, protopanaxadiol and protopanaxatriol.

### Claim 51 (depends on 50)

The method of claim 50, wherein the UGT enzyme(s) are capable of catalyzing glycosylation of C3—OH, C6—OH, and/or C20—OH, and optionally one or more branching glycosylations.

### Claim 52 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51)

The method of any one of claims 1 to 51, wherein the heterologous biosynthetic pathway further comprises a squalene synthase (SQS) enzyme.

### Claim 53 (depends on 52)

The method of claim 52, wherein the SQS comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to an amino acid sequence selected from SEQ ID NOs: 1 and 23-38.

### Claim 54 (depends on 53)

The method of claim 53, wherein the SQS comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to an amino acid sequence selected from SEQ ID NO: 1.

### Claim 55 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

The method of any one of claims 1 to 54, wherein the heterologous biosynthetic pathway further comprises a squalene epoxidase (SQE).

### Claim 56 (depends on 55)

The method of claim 55, wherein the SQE comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to an amino acid sequence selected from SEQ ID NOs: 2 and 39-70.

### Claim 57 (depends on 56)

The method of claim 56, wherein the SQE enzyme comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 2.

### Claim 58 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

The method of any one of claims 1 to 57, wherein the microbial host cell expresses an enzymatic pathway that produces iso-pentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP).

### Claim 59 (depends on 58)

The method of claim 58, wherein the enzymatic pathway is a methylerythritol phosphate (MEP) pathway and/or a mevalonic acid (MVA) pathway.

### Claim 60 (depends on 59)

The method of claim 59, wherein the microbial host cell is a bacterium that produces increased MEP pathway products.

### Claim 61 (depends on 59, 60)

The method of claim 59 or 60, wherein the bacterium is selected from Escherichia coli, Bacillus subtilis, Corynebacterium glutamicum, Rhodobacter capsulatus, Rhodobacter sphaeroides, Zymomonas mobilis, Vibrio natriegens, and Pseudomonas putida.

### Claim 62 (depends on 61)

The method of claim 61, wherein the microbial host cell is E. coli.

### Claim 63 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The method of any one of claims 1 to 62, wherein the microbial host is a yeast, optionally selected from a species of Saccharomyces, Pichia, or Yarrowia, and which is optionally Saccharomyces cerevisiae, Pichia pastoris, and Yarrowia lipolytica.

### Claim 64 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63)

The method of any one of claims 1 to 63, wherein the microbial host cell is cultured in a carbon source comprising glucose, sucrose, fructose, xylose, and/or glycerol.

### Claim 65 (depends on 64)

The method of claim 64, wherein culture conditions are selected from aerobic, microaerobic, and anaerobic.

### Claim 66 (depends on 65)

The method of claim 65, wherein the microbial host cell is cultured at a temperature in the range of about 22° C. to about 37° C., or about 27° C. to about 37° C., or about 30° C. to about 37° C.

### Claim 67 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)

The method of any one of claims 1 to 66, wherein dammaranediol, protopanaxadiol, protopanaxatriol or a glycosylated derivative thereof is recovered from the culture.

### Claim 68

A microbial host cell producing dammarenediol or a derivative thereof, the microbial host cell expressing a heterologous biosynthetic pathway producing dammarenediol or a derivative thereof, the heterologous biosynthetic pathway comprising one or more of:
a dammarenediol synthase (DDS) enzyme comprising an amino acid sequence that has at least about 70% sequence identity to the amino acid sequence of SEQ ID NO: 3, SEQ ID NO: 4, or SEQ ID NO: 9;
a protopanaxadiol synthase (PPDS) enzyme comprising an amino acid sequence that has at least 70% sequence identity to the amino acid sequence of SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 14, SEQ ID NO: 15, or SEQ ID NO: 16; and
a protopanaxatriol synthase (PPTS) enzyme comprising an amino acid sequence that has at least 70% sequence identity to the amino acid sequence of SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, and SEQ ID NO: 21.

### Claim 69 (depends on 68)

The microbial host cell of claim 68, wherein the DDS enzyme comprises an amino acid sequence having at least 80% sequence identity, or at least 85% sequence identity, or at least 90% sequence identity, or at least 95% sequence identity, or at least 97% sequence identity, or at least 98% sequence identity, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 3, SEQ ID NO: 4, or SEQ ID NO: 9.

### Claim 70 (depends on 68)

The microbial host cell of claim 68, wherein the DDS enzyme comprises an amino acid sequence having at least 70% sequence identity, or at least 80% sequence identity, or at least 85% sequence identity, or at least 90% sequence identity, or at least 95% sequence identity, or at least 97% sequence identity, or at least 98% sequence identity, or at least 99% sequence identity to SEQ ID NO: 3.

### Claim 71 (depends on 70)

The microbial host cell of claim 70, wherein the DDS enzyme comprises from 1 to 20, or from 1 to 10, or from 1 to 5 amino acid substitutions with respect to SEQ ID NO: 3.

### Claim 72 (depends on 70, 71)

The microbial host cell of claim 70 or claim 71, wherein the DDS enzyme comprises one or more substitutions at positions selected from 30, 64, 68, 365, 369, 425, 461, 465, 468, 606, 628, and 632 with respect to SEQ ID NO: 3.

### Claim 73 (depends on 72)

The microbial host cell of claim 72, wherein the DDS enzyme comprises at least 2, or at least 3, or at least 4, or more substitutions at positions selected from 30, 64, 68, 365, 369, 425, 461, 465, 468, 606, 628, and 632 with respect to SEQ ID NO: 3.

### Claim 74 (depends on 73)

The microbial host cell of claim 73, wherein the DDS enzyme comprises one or more substitutions selected from N606I, N606L, N606V, T628A, T628V, T628G, F632L, F632I, F632V, and F632A with respect to SEQ ID NO: 3.

### Claim 75 (depends on 74)

The microbial host cell of claim 74, wherein the DDS enzyme comprises one or more substitutions selected from N606I, T628A, and F632L with respect to SEQ ID NO: 3, and wherein the DDS enzyme optionally comprises the amino acid sequence of SEQ ID NO: 5.

### Claim 76 (depends on 71, 72, 73, 74, 75)

The microbial host cell of any one of claims 71 to 75, wherein the DDS enzyme comprises one or more substitutions at positions selected from 365, 369, and 461 with respect to SEQ ID NO: 3.

### Claim 77 (depends on 76)

The microbial host cell of claim 76, wherein the DDS enzyme comprises one or more substitutions selected from T365E, T365D, F369Y, R461T, and R461S with respect to SEQ ID NO: 3.

### Claim 78 (depends on 77)

The microbial host cell of claim 77, wherein the DDS enzyme comprises one or more substitutions selected from T365E, F369Y, and R461S with respect to SEQ ID NO: 3, and wherein the DDS enzyme optionally comprises the amino acid sequence of SEQ ID NO: 6.

### Claim 79 (depends on 71, 72, 73, 74, 75, 76, 77, 78)

The microbial host cell of any one of claims 71 to 78, wherein the DDS enzyme comprises one or more substitutions at positions selected from 30, 64, and 68 with respect to SEQ ID NO: 3.

### Claim 80 (depends on 79)

The microbial host cell of claim 79, wherein the DDS enzyme comprises one or more substitutions selected from Q30D, Q30E, M64L, M64I, M64V, M64A, and R68M with respect to SEQ ID NO: 3.

### Claim 81 (depends on 80)

The microbial host cell of claim 80, wherein the DDS enzyme comprises one or more substitutions selected from Q30D, M64L, and R68M with respect to SEQ ID NO: 3, wherein the DDS enzyme optionally comprises the amino acid sequence of SEQ ID NO: 7.

### Claim 82 (depends on 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81)

The microbial host cell of any one of claims 71 to 81, wherein the DDS enzyme comprises one or more substitutions at positions selected from 425, 465, and 468 with respect to SEQ ID NO: 3.

### Claim 83 (depends on 82)

The microbial host cell of claim 82, wherein the DDS enzyme comprises one or more substitutions selected from L465K, L465R, L465H, C468Y, C468F, C468W, I425G, I425V, and I425A with respect to SEQ ID NO: 3.

### Claim 84 (depends on 83)

The microbial host cell of claim 83, wherein the DDS enzyme comprises one or more substitutions selected from L465K, C468Y, and I425A with respect to SEQ ID NO: 3, wherein the DDS enzyme optionally comprises the amino acid sequence of SEQ ID NO: 8.

### Claim 85 (depends on 70, 71)

The microbial host cell of claim 70 or 71, wherein the DDS enzyme comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 7, and has one or more substitutions with respect to SEQ ID NO: 7 selected from: T364E, T364D, F368Y, R460S, R460T, L464K, L464R, C467Y, and I424A.

### Claim 86 (depends on 85)

The microbial host cell of claim 85, wherein the DDS enzyme comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 7, and has two, three, or more substitutions with respect to SEQ ID NO: 7 selected from: T364E, F368Y, R460S, L464K, C467Y, and I424A.

### Claim 87 (depends on 86)

The microbial host cell of claim 86, wherein the DDS enzyme comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 7, and has at least the following substitutions with respect to SEQ ID NO: 7: T364E, F368Y, R460S, L464K, C467Y, and I424A, and wherein the DDS enzyme optionally has the amino acid sequence of SEQ ID NO: 81.

### Claim 88 (depends on 68)

The microbial host cell of claim 68, wherein the DDS enzyme comprises an amino acid sequence that is at least 90% identical, or at least 95% identical, or at least 97% identical, or at least 98% identical to SEQ ID NO: 81.

### Claim 89 (depends on 88)

The microbial host cell of claim 88, wherein the DDS enzymes comprises one or more mutations with respect to SEQ ID NO: 81 listed in Table 1.

### Claim 90 (depends on 87)

The microbial host cell of claim 87, wherein the DDS enzymes comprises two, three, four, five, or more mutations with respect to SEQ ID NO: 81 listed in Table 1.

### Claim 91 (depends on 89)

The microbial host cell of claim 89, wherein the DDS enzyme has one or more of the following mutations with respect to SEQ ID NO: 81: Y49F, S181T, deletion of amino acids L195-E197, S198P, E238S, I407V, D507E, R637K, and M695I, and the DDS enzyme optionally comprises the amino acid sequence of SEQ ID NO: 82.

### Claim 92 (depends on 68)

The microbial host cell of claim 68, wherein the heterologous pathway comprises DDS enzyme comprising an amino acid sequence that is at least 90% identical, or at least 95% identical, or at least 97% identical, or at least 98% identical to SEQ ID NO: 82.

### Claim 93 (depends on 92)

The microbial host cell of claim 92, wherein the DDS enzymes comprises one or more mutations with respect to SEQ ID NO: 82 listed in Table 2.

### Claim 94 (depends on 93)

The microbial host cell of claim 93, wherein the DDS enzymes comprises two, three, four, five, or more mutations with respect to SEQ ID NO: 82 listed in Table 2.

### Claim 95 (depends on 94)

The microbial host cell of claim 94, wherein the DDS enzyme comprises one or more mutations with respect to SEQ ID NO: 82 selected from: F649L, F649V, F649I, F649A, L548F, Q149E, Q149D, A120S, A120T, G573A, G573L, S380A, S380G, and A256G.

### Claim 96 (depends on 95)

The microbial host cell of claim 95, wherein the DDS enzyme comprises two, three, four, five, or all mutations with respect to SEQ ID NO: 82 selected from: F649L, L548F, Q149E, A120S, G573A, S380A, and A256G.

### Claim 97 (depends on 68)

The microbial host cell of claim 68, wherein the heterologous biosynthetic pathway comprises a DDS enzyme comprising an amino acid sequence that is at least 90%, or at least 95%, or at least 97%, or at least 98%, or at least 99% identical to SEQ ID NO: 85.

### Claim 98 (depends on 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97)

The microbial host cell of any one of claims 68 to 97, wherein the heterologous biosynthetic pathway comprises a PPDS enzyme comprising an amino acid sequence that has at least 70% sequence identity to the amino acid sequence of SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 14, SEQ ID NO: 15, or SEQ ID NO: 16.

### Claim 99 (depends on 98)

The microbial host cell of claim 98, wherein the PPDS enzyme comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to an amino acid sequence selected from SEQ ID NOs: 10, 11, 12 and 16.

### Claim 100 (depends on 98)

The microbial host cell of claim 98, wherein the PPDS enzyme comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 10.

### Claim 101 (depends on 100)

The microbial host cell of claim 100, wherein the PPDS enzyme comprises from 1 to 20, or from 1 to 10, or from 1 to 5 amino acid substitutions with respect to SEQ ID NO: 10.

### Claim 102 (depends on 100, 101)

The microbial host cell of claim 100 or claim 101, wherein the PPDS enzyme comprises one or more substitutions selected from N58D, N58E, S68P, R85K, I95V, L96F, L96W, L96Y, T108N, T108Q, D135E, M144L, M144V, M144I, V150P, G152A, G152L, G152I, G152V, M153L, M153I, M153V, M153A, F167H, S192A, S192G, E202P, I212F, R243K, R243H, V248I, V248L,N277D, N277E, Q278E, Q278D, L283M, L292I, L292V, L292A, F317L, F317I, F317V, F317A, V329M, N333K, N333R, K338G, K338A, L346I, R347Q, R347N, I362L, I362V, I362A, M390L, M390I, M390V, M390A, H482R, and H482K with respect to SEQ ID NO: 10.

### Claim 103 (depends on 102)

The microbial host cell of claim 102, wherein the PPDS enzyme comprises at least 2, or at least 3, or at least 4, or at least 5, or at least 8, or at least 10 amino acid substitutions listed in Table 3.

### Claim 104 (depends on 103)

The microbial host cell of claim 103, wherein the PPDS enzyme comprises at least one, two, three, four, five, six, seven, eight, or all of the following mutations with respect to SEQ ID NO: 10: T108N, I212F, K338G, D135E, S68P, V150P, F167H, L283M, H482R, R347Q, M390L, R243K, L292I, V329M, Q278E, and N58E.

### Claim 105 (depends on 104)

The microbial host cell of claim 104, wherein the PPDS comprises the amino acid sequence of SEQ ID NO: 83, optionally with from 1 to 10 or from 1 to 5 amino acid modifications independently selected from substitutions, insertions, and deletions.

### Claim 106 (depends on 68)

The microbial host cell of claim 68, wherein the heterologous biosynthetic pathway comprises a PPDS enzyme comprising an amino acid sequence that is at least 90%, or at least 95%, or at least 97%, or at least 98%, or at least 99% identical to SEQ ID NO: 83.

### Claim 107 (depends on 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106)

The microbial host cell of any one of claims 68 to 106, wherein the heterologous biosynthetic pathway comprises a PPTS enzyme comprising an amino acid sequence that has at least 70% sequence identity to an amino acid sequence selected from SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20 and SEQ ID NO: 21.

### Claim 108 (depends on 106)

The microbial host cell of claim 106, wherein the PPTS enzyme comprises an amino acid sequence that has at least 70% sequence identity, or at least 80% sequence identity, or at least 85% sequence identity, or at least 90% sequence identity, or at least 95% sequence identity, or at least 97% sequence identity, or at least 98% sequence identity to an amino acid sequence selected from SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20 and SEQ ID NO: 21.

### Claim 109 (depends on 107)

The microbial host cell of claim 107, wherein the PPTS enzyme comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 17.

### Claim 110 (depends on 109)

The microbial host cell of claim 109, wherein the PPTS enzyme comprises from 1 to 20, or from 1 to 10, or from 1 to 5 amino acid substitutions with respect to SEQ ID NO: 17.

### Claim 111 (depends on 109, 110)

The microbial host cell of claim 109 or 110, wherein the PPTS enzyme comprises one or more substitutions with respect to SEQ ID NO: 17 selected from: I98L, I98V, I98A, A113S, A120S, A120T, K146R, F147Y, S166K, S166R, E176K, E176R, W185R, W185K, L187F, L187Y, L187W, L215I, F217L, F217I, F217V, F217A, V239I, V239L, V239A, R244K, K247L, K247V, K247I, K247A, Q249E, Q249D, T250P, K252Q, K252N, M259L, M259I, M259V, V278I, G294T, G294S, A323P, E324G, E324A, S328N, S328Q, R334K, V358E, V358D, V359A, V359G, K362D, K362E, S364T, N367G, N367A, I369T, I369S, K391P, M407A, M407G, F409Y, I412V, F426Y, V431I, V431L, N463K, N463R, and C472H.

### Claim 112 (depends on 111)

The microbial host cell of claim 111, wherein the PPTS enzyme comprises at least 2, or at least 3, or at least 4, or at least 5, or at least 8, or at least 10 amino acid substitutions with respect to SEQ ID NO: 17 as listed in Table 4.

### Claim 113 (depends on 112)

The microbial host cell of claim 112, wherein the PPTS enzyme comprises at least two, at least 3, at least 4, at least 5, or all amino acid substitutions selected from SEQ ID NO: 17 selected from: G294T, S166K, C472H, K252Q, V239I, A323P, I412V, I369T, K362D, and T250P.

### Claim 114 (depends on 113)

The microbial of claim 113, wherein the PPTS comprises the amino acid sequence of SEQ ID NO: 84, optionally with from 1 to 10 or from 1 to 5 amino acid modifications independently selected from substitutions, insertions, and deletions.

### Claim 115 (depends on 68)

The microbial host cell of claim 68, wherein the heterologous biosynthetic pathway comprises a PPTS enzyme comprising an amino acid sequence that is at least 90%, or at least 95%, or at least 97%, or at least 98%, or at least 99% identical to SEQ ID NO: 84.

### Claim 116 (depends on 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115)

The microbial host cell of any one of claims 68 to 115, wherein the heterologous biosynthetic pathway further comprises one or more uridine diphosphate-dependent glycosyltransferase (UGT) enzymes that glycosylate one or more of dammaranediol, protopanaxadiol and protopanaxatriol.

### Claim 117 (depends on 116)

The microbial host cell of claim 116, wherein the UGT enzyme(s) are capable of catalyzing glycosylation of C3—OH, C6—OH, and/or C20—OH, and optionally one or more branching glycosylations.

### Claim 118 (depends on 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117)

The microbial host cell of any one of claims 68 to 117, wherein the heterologous biosynthetic pathway further comprises a squalene synthase (SQS) enzyme.

### Claim 119 (depends on 118)

The microbial host cell of claim 118, wherein the SQS comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to an amino acid sequence selected from SEQ ID NOs: 1 and 23-38.

### Claim 120 (depends on 119)

The microbial host cell of claim 119, wherein the SQS comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to an amino acid sequence selected from SEQ ID NO: 1.

### Claim 121 (depends on 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120)

The microbial host cell of any one of claims 68 to 120, wherein the heterologous biosynthetic pathway further comprises a squalene epoxidase (SQE).

### Claim 122 (depends on 121)

The microbial host cell of claim 121, wherein the SQE comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to an amino acid sequence selected from SEQ ID NOs: 2 and 39-70.

### Claim 123 (depends on 121)

The microbial host cell of claim 121, wherein the SQE enzyme comprises an amino acid sequence having at least 70%, or at least 80%, or at least 85%, or at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 2.

### Claim 124 (depends on 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123)

The microbial host cell of any one of claims 68 to 123, wherein the microbial host cell expresses an enzymatic pathway that produces iso-pentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP).

### Claim 125 (depends on 124)

The microbial host cell of claim 124, wherein the enzymatic pathway is a methylerythritol phosphate (MEP) pathway and/or a mevalonic acid (MVA) pathway.

### Claim 126 (depends on 125)

The microbial host cell of claim 125, wherein the microbial host cell is a bacterium that produces increased MEP pathway products.

### Claim 127 (depends on 125, 126)

The microbial host cell of claim 125 or 126, wherein the bacterium is selected from Escherichia coli, Bacillus subtilis, Corynebacterium glutamicum, Rhodobacter capsulatus, Rhodobacter sphaeroides, Zymomonas mobilis, Vibrio natriegens, and Pseudomonas putida.

### Claim 128 (depends on 127)

The microbial host cell of claim 127, wherein the microbial host cell is E. coli.

### Claim 129 (depends on 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125)

The microbial host cell of any one of claims 68 to 125, wherein the microbial host is a yeast, optionally selected from a species of Saccharomyces, Pichia, or Yarrowia, and which is optionally Saccharomyces cerevisiae, Pichia pastoris, and Yarrowia lipolytica.

### Claim 130

A dammarenediol synthase (DDS) enzyme comprising an amino acid sequence that is at least 90% or at least 95%, or at least 97%, or at least 98% identical to SEQ ID NO: 3, wherein the DDS has one or more of:
one or more substitutions selected from N606I, N606L, N606V, T628A, T628V, T628G, F632L, F632I, F632V, and F632A with respect to SEQ ID NO: 3;
one or more substitutions selected from T365E, T365D, F369Y, R461T, and R461S with respect to SEQ ID NO: 3;
one or more substitutions selected from Q30D, Q30E, M64L, M64I, M64V, M64A, and R68M with respect to SEQ ID NO: 3; and
one or more substitutions selected from L465K, L465R, L465H, C468Y, C468F, C468W, I425G, I425V, and I425A with respect to SEQ ID NO: 3.

### Claim 131 (depends on 130)

The DDS enzyme of claim 130, wherein the DDS enzyme comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 7, and optionally has at least the following substitutions with respect to SEQ ID NO: 7: T364E, F368Y, R460S, L464K, C467Y, and I424A, and wherein the DDS enzyme optionally has the amino acid sequence of SEQ ID NO: 81.

### Claim 132 (depends on 131)

The DDS enzyme of claim 131, wherein the DDS enzymes comprises one or more mutations with respect to SEQ ID NO: 81 listed in Table 1, optionally wherein the DDS enzymes comprises two, three, four, five, or more mutations with respect to SEQ ID NO: 81 listed in Table 1.

### Claim 133 (depends on 132)

The DDS enzyme of claim 132, wherein the DDS enzyme has one or more of the following mutations with respect to SEQ ID NO: 81: Y49F, S181T, deletion of amino acids L195-E197, S198P, E238S, I407V, D507E, R637K, and M695I, and the DDS enzyme optionally comprises the amino acid sequence of SEQ ID NO: 82.

### Claim 134 (depends on 133)

The DDS enzyme of claim 133, wherein the DDS enzymes comprises one or more mutations with respect to SEQ ID NO: 82 listed in Table 2, optionally wherein the DDS enzymes comprises two, three, four, five, or more mutations with respect to SEQ ID NO: 82 listed in Table 2.

### Claim 135 (depends on 134)

The DDS enzyme of claim 134, wherein the DDS enzyme comprises one or more mutations with respect to SEQ ID NO: 82 selected from: F649L, F649V, F649I, F649A, L548F, Q149E, Q149D, A120S, A120T, G573A, G573L, S380A, S380G, and A256G, optionally wherein the DDS enzyme comprises two, three, four, five, or all mutations with respect to SEQ ID NO: 82 selected from: F649L, L548F, Q149E, A120S, G573A, S380A, and A256G.

### Claim 136 (depends on 130)

The DDS enzyme of claim 130, wherein the DDS enzyme comprises an amino acid sequence that is at least 95%, or at least 97%, or at least 98%, or at least 99% identical to SEQ ID NO: 85.

### Claim 137

A protopanaxadiol synthase (PPDS) enzyme comprising an amino acid sequence having at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 10, wherein the PPDS enzyme comprises one or more substitutions selected from N58D, N58E, S68P, R85K, I95V, L96F, L96W, L96Y, T108N, T108Q, D135E, M144L, M144V, M144I, V150P, G152A, G152L, G152I, G152V, M153L, M153I, M153V, M153A, F167H, S192A, S192G, E202P, I212F, R243K, R243H, V248I, V248L,N277D, N277E, Q278E, Q278D, L283M, L292I, L292V, L292A, F317L, F317I, F317V, F317A, V329M, N333K, N333R, K338G, K338A, L346I, R347Q, R347N, I362L, I362V, I362A, M390L, M390I, M390V, M390A, H482R, and H482K with respect to SEQ ID NO: 10.

### Claim 138 (depends on 137)

The PPDS enzyme of claim 137, wherein the PPDS enzyme comprises at least 2, or at least 3, or at least 4, or at least 5, or at least 8, or at least 10 amino acid substitutions with respect to SEQ ID NO: 10 listed in Table 3.

### Claim 139 (depends on 138)

The PPDS enzyme of claim 138, wherein the PPDS enzyme comprises at least one, two, three, four, five, six, seven, eight, or all of the following mutations with respect to SEQ ID NO: 10: T108N, I212F, K338G, D135E, S68P, V150P, F167H, L283M, H482R, R347Q, M390L, R243K, L292I, V329M, Q278E, and N58E.

### Claim 140 (depends on 138)

The PPDS enzyme of claim 138, wherein the PPDS comprises the amino acid sequence of SEQ ID NO: 83, optionally with from 1 to 10 or from 1 to 5 amino acid modifications independently selected from substitutions, insertions, and deletions.

### Claim 141 (depends on 137)

The PPDS enzyme of claim 137, wherein the PPDS enzyme comprises an amino acid sequence that is at least 95%, or at least 97%, or at least 98%, or at least 99% identical to SEQ ID NO: 83.

### Claim 142

A protopanaxatriol synthase (PPTS) enzyme, comprising an amino acid sequence having at least 90%, or at least 95%, or at least 98%, or at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 17, wherein the PPTS enzyme comprises one or more substitutions with respect to SEQ ID NO: 17 selected from: 198L, 198V, 198A, A113S, A120S, A120T, K146R, F147Y, S166K, S166R, E176K, E176R, W185R, W185K, L187F, L187Y, L187W, L215I, F217L, F217I, F217V, F217A, V239I, V239L, V239A, R244K, K247L, K247V, K247I, K247A, Q249E, Q249D, T250P, K252Q, K252N, M259L, M259I, M259V, V278I, G294T, G294S, A323P, E324G, E324A, S328N, S328Q, R334K, V358E, V358D, V359A, V359G, K362D, K362E, S364T, N367G, N367A, I369T, I369S, K391P, M407A, M407G, F409Y, I412V, F426Y, V431I, V431L, N463K, N463R, and C472H, with respect to SEQ ID NO: 17.

### Claim 143 (depends on 142)

The PPTS enzyme of claim 142, wherein the PPTS enzyme comprises at least 2, or at least 3, or at least 4, or at least 5, or at least 8, or at least 10 amino acid substitutions with respect to SEQ ID NO: 17 as listed in Table 4.

### Claim 144 (depends on 143)

The PPTS enzyme of claim 143, wherein the PPTS enzyme comprises at least two, at least 3, at least 4, at least 5, or all amino acid substitutions selected from SEQ ID NO: 17 selected from: G294T, S166K, C472H, K252Q, V239I, A323P, I412V, I369T, K362D, and T250P.

### Claim 145 (depends on 143, 144)

The PPTS enzyme of claim 143 or 144, wherein the PPTS comprises the amino acid sequence of SEQ ID NO: 84, optionally with from 1 to 10 or from 1 to 5 amino acid modifications independently selected from substitutions, insertions, and deletions.

### Claim 146 (depends on 142)

The PPTS enzyme of claim 142, wherein the PPTS enzyme comprising an amino acid sequence that is at least 95%, or at least 97%, or at least 98%, or at least 99% identical to SEQ ID NO: 84.
